Podcast: Why Biotech CEOs Should Prepare Now for All Opportunities

With the JPMorgan Healthcare Conference on the horizon, biotech CEOs are wondering whether the new year will bring a more welcoming IPO market. But Gregg Beloff, co-founder and managing director of Danforth Advisors, said rather than focus on an IPO, companies should prepare themselves to capitalize on a range of financing options that may present themselves. We spoke to Beloff about what CEOs should do now to get their companies positioned for different financing options, how they can de-risk themselves, and the things it is never too early to do so they can capitalize on opportunities when they arise.